Product News
Neoantigen Specific Peptide Synthesis Service for Precision Immuno-oncology Therapeutic Development
The new service from GenScript aims to overcome the challenges of manufacturing difficult neoantigen peptides critical to personalized cancer vaccine and T-cell therapy generation.
Product News
PCR Biosystems Scales Up Operations to Ensure Availability of COVID-19 Test Reagents
PCR Biosystems are continuing to scale up operations to ensure the critical enzyme mix for COVID-19 tests remain available to the UK and global healthcare systems as demand for testing rises.
Product News
Clinical Validation of Portable Rapid Testing Kit for Coronavirus
MicrosensDx has announced that the test for research use in the detection of RNA from the SARS-Cov-2 virus in sputum, throat and nose swabs has now been assessed for clinical performance
Product News
Success in Next Phase of Open Source Malaria Initiative
Optibrium™ and Intellegens™ have successfully completed phase 2 of a global challenge aimed at developing and testing novel antimalarial compounds.
Product News
Proteomics Enters the COVID-19 Fight
SomaLogic has launched a new initiative to deploy their proteomic technology against the coronavirus pandemic.
Product News
Life Sciences Hub Wales Calls for Industry Collaboration To Fight Coronavirus
Wales’ leading organization for healthcare innovation is calling on companies and innovators from across the country to join the fight against coronavirus.
Product News
2020 Eppendorf Award for Young European Investigators Announced
The independent Eppendorf Award Jury has selected Prof. Dr. Randall J. Platt, Assistant Professor of Biological Engineering, ETH Zurich, Switzerland, as the 2020 winner of the Eppendorf Award for Young European Investigators.
Product News
Carterra to Provide Antibody Screening and Characterization for the Coronavirus Immunotherapy Consortium (CoVIC)
Carterra® Inc. and La Jolla Institute for Immunology (LJI) have announced that they will use Carterra’s proprietary LSA™ platform to screen hundreds of antibodies in just a few days.
Product News
Developing a COVID-19 Vaccine: Cobra Biologics Part of ChAdOx1 Consortium
Cobra Biologics has announced it is working as part of a consortium led by the Jenner Institute, Oxford University to rapidly develop, scale-up and produce the potential adenoviral vaccine candidate, ChAdOx1 nCov-19 (ChAdOx1), for fast-tracked clinical trials for COVID-19.
Product News
Amoéba Biocontrol Products Selected for Evaluation on European Vineyards
Amoéba has announced the signature of a Material Transfer Agreement (MTA) with Certis Europe; the purpose of the research partnership is the delivery by Amoéba of experimental biocontrol products for crop protection.
Advertisement